These results underscore genotoxic agents as critical modulators of the IL-6 signaling pathway, potentially via regulating the levels of IL-6, but not membrane-bound IL-6Rα, in cancer cells, especially in p53 wild-type (WT) cells. Here, TP53 is linked to cancer.